Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database
- PMID: 27158754
- DOI: 10.1097/PAS.0000000000000655
Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database
Abstract
An accurate histopathologic diagnosis is essential for an adequate treatment of soft tissue sarcomas. The diagnosis of malignant peripheral nerve sheath tumor (MPNST) can be complex, particularly outside the neurofibromatosis type 1 (NF1) context. MPNST is a rare malignancy, and due to the lack of specific histologic criteria, several differential diagnoses must be considered. A total of 350 patients diagnosed with MPNST (from 1990 to 2013) were retrieved from the French sarcoma network (RRePS) and the Conticabase (Connective Tissue Cancer Network database). Tumor samples were available for 160 cases (45.2%). Pathology review, immunohistochemistry (IHC), and molecular analysis (when dealing with a monomorphic sarcoma) were systematically performed. Patient, tumor, and treatment characteristics were evaluated to identify prognostic factors for the definitive primary MPNST (n=106) cohort. Twenty-nine tumors (18.1%) initially diagnosed as MPNST were reclassified on the basis of histologic review, IHC, and molecular analysis. Patients with NF1 disease comprised 64% of the remaining cohort. The 5-year overall survival for patients from the entire cohort was 47%, 34.8% for NF1 patients, and 68.5% for patients without NF1 disease, making NF1 syndrome an independent poor prognostic factor of survival. Positive margins and lack of radiation therapy were independent predictors of local recurrence. The Fédération Nationale des Centres de Lutte Contre le Cancer tumor grade was an independent prognostic indicator of metastasis. Given the therapeutic implications of a misdiagnosis, the systematic pathology review, IHC, and molecular analysis (when dealing with monomorphic sarcoma) strategy allowed reclassification of 20% of cases, mainly the sporadic MPNSTs.
Similar articles
-
A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.Head Neck Pathol. 2018 Jun;12(2):151-159. doi: 10.1007/s12105-017-0841-y. Epub 2017 Jul 31. Head Neck Pathol. 2018. PMID: 28762137 Free PMC article.
-
Malignant Peripheral Nerve Sheath Tumor.Surg Oncol Clin N Am. 2016 Oct;25(4):789-802. doi: 10.1016/j.soc.2016.05.009. Surg Oncol Clin N Am. 2016. PMID: 27591499 Review.
-
Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.J Neurosurg. 2017 Jan;126(1):319-329. doi: 10.3171/2015.12.JNS152443. Epub 2016 Apr 1. J Neurosurg. 2017. PMID: 27035165 Free PMC article.
-
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).Eur J Cancer. 2016 Mar;56:77-84. doi: 10.1016/j.ejca.2015.12.015. Epub 2016 Jan 26. Eur J Cancer. 2016. PMID: 26824706
-
Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.Auris Nasus Larynx. 2010 Oct;37(5):539-45. doi: 10.1016/j.anl.2010.02.009. Auris Nasus Larynx. 2010. PMID: 20399579 Review.
Cited by
-
Chronic kidney disease with malignant peripheral nerve sheath tumor of the ureter: a case report.Front Oncol. 2024 May 2;14:1368996. doi: 10.3389/fonc.2024.1368996. eCollection 2024. Front Oncol. 2024. PMID: 38756660 Free PMC article.
-
Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors.Mol Ther Oncol. 2024 Feb 28;32(2):200783. doi: 10.1016/j.omton.2024.200783. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38595983 Free PMC article.
-
Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.World J Surg Oncol. 2024 Jan 9;22(1):14. doi: 10.1186/s12957-023-03296-z. World J Surg Oncol. 2024. PMID: 38191386 Free PMC article.
-
Malignant peripheral nerve sheath tumor with hemophilic syndrome and bone marrow fibrosis: A rare case report.World J Clin Cases. 2023 Nov 6;11(31):7673-7679. doi: 10.12998/wjcc.v11.i31.7673. World J Clin Cases. 2023. PMID: 38078124 Free PMC article.
-
The role of radiotherapy in the management of malignant peripheral nerve sheath tumors: a single-center retrospective cohort study.J Cancer Res Clin Oncol. 2023 Dec;149(20):17739-17747. doi: 10.1007/s00432-023-05449-9. Epub 2023 Nov 4. J Cancer Res Clin Oncol. 2023. PMID: 37924493 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous